Hybrid identity and distinct methylation profiles of incomplete intestinal metaplasia in the stomach [0.03%]
胃部不完全肠上皮化生的混合身份及其表观特征
Hyesung Kim,Junseong Kim,In Ho Jeong et al.
Hyesung Kim et al.
Background: Gastric intestinal metaplasia (GIM), particularly the incomplete subtype (Inc IM), is strongly associated with increased gastric cancer (GC) risk. However, its role as a true precursor lesion remains uncertain...
Knut E A Lundin,Katri Lindfors,Louise Fremgaard Risnes
Knut E A Lundin
Balancing safety and recurrence: pooled analysis of cold snare EMR for large colorectal polyps [0.03%]
平衡安全和复发性：冷活检钳黏膜切除术治疗大结肠息肉的汇总分析
Baobao Wang,Qingzhou Kong,Yue-Yue Li et al.
Baobao Wang et al.
Endoscopic intermuscular dissection for rectal cancer: are we ready to skip surgery? [0.03%]
经内镜肌层解剖在直肠癌治疗中取代手术的位置了吗？
Katsuro Ichimasa,Shin-Ei Kudo,Masashi Misawa
Katsuro Ichimasa
Hepatocyte senescence in alcohol-associated hepatitis: epiphenomenon or disease-driving mechanism? [0.03%]
酒精性肝炎中肝细胞衰老：伴随现象还是疾病驱动机制？
Adrien Guillot,Elisa Pose
Adrien Guillot
Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring [0.03%]
非侵入性检测在MASLD管理中的应用：革新诊断、疾病进展和逆转监测方法
Gong Feng,Vincent Wai-Sun Wong,Giovanni Targher et al.
Gong Feng et al.
With the recent conditional approval of resmetirom by the US Food and Drug Administration, the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) has potentially entered a new era, requiring a comprehensive unders...
To be or not to be (a biliary cancer): RAS (signalling) is the question [0.03%]
生死由命（抑或胆道肿瘤）：RAS（信号转导）定风波
Konstantina Morali,Silvestre Vicent
Konstantina Morali
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions [0.03%]
Hp抗生素耐药性：一个亟待解决的全球问题
Christian Schulz,Jyh-Ming Liou,Mohamed Alboraie et al.
Christian Schulz et al.
Background: Helicobacter pylori resistance to antibiotics commonly used in eradication regimens is increasing dramatically in many locations; new strategies are needed to manage this infectious disease. ...
Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α [0.03%]
通过新型分阶段联合治疗甘氨酸和干扰素-α抑制乙型肝炎表面抗原和cccDNA的研究
Caorui Lin,Ying Huang,Ning Ran et al.
Caorui Lin et al.
Background: The elimination of HBV covalently closed circular DNA (cccDNA) remains a critical hurdle for chronic hepatitis B (CHB) management. Objective: ...
William Fusco,Timon Adolph,Giovanni Cammarota et al.
William Fusco et al.
Atherosclerosis reflects a chronic inflammatory process of arteries. The origin of chronic vascular inflammation has been associated over a long time primarily with lipid disorders, but evidence from the past years has suggested that lipid-...